We are live on ! Find out more
NRD

Nebula Research & Development Portfolio holdings

AUM $1.17B
1-Year Est. Return 15.19%
This Fund
S&P 500
This Quarter Est. Return
-6.2%
1 Year Est. Return
+15.19%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$190M
AUM Growth
+$57.8M
Cap. Flow
+$73.8M
Cap. Flow %
38.92%
Top 10 Hldgs %
5.1%
Holding
699
New
375
Increased
49
Reduced
49
Closed
226

Top Buys

Rank Stock Value
1
LPX icon
Louisiana-Pacific
LPX
+$1.14M
2
DG icon
Dollar General
DG
+$1.14M
3
POWI icon
Power Integrations
POWI
+$1.09M
4
DOC icon
Healthpeak Properties
DOC
+$1.08M
5
HCA icon
HCA Healthcare
HCA
+$1.08M

Top Sells

Rank Stock Value
1
O icon
Realty Income
O
+$636K
2
SLG icon
SL Green Realty
SLG
+$636K
3
NXE icon
NexGen Energy
NXE
+$632K
4
FIS icon
Fidelity National Information Services
FIS
+$631K
5
NTR icon
Nutrien
NTR
+$631K

Sector Composition

Rank Sector Weight
1 Technology 17.57%
2 Industrials 16.5%
3 Healthcare 14.54%
4 Financials 10.48%
5 Consumer Discretionary 10.01%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
HBM icon
401
Hudbay
HBM
$9.96B
$198K 0.1%
+40,660
New +$206K
LADR
402
Ladder Capital
LADR
$1.24B
$197K 0.1%
+19,158
New +$207K
DNB
403
DELISTED
Dun & Bradstreet
DNB
$196K 0.1%
+19,648
New +$217K
SKIN icon
404
SkinHealth Systems
SKIN
$96.9M
$196K 0.1%
+32,510
New +$228K
BRSP
405
BrightSpire Capital
BRSP
$683M
$196K 0.1%
+31,236
New +$214K
MFA
406
MFA Financial
MFA
$927M
$195K 0.1%
+20,296
New +$220K
AIV
407
Aimco
AIV
$377M
$193K 0.1%
+28,368
New +$226K
DLX icon
408
Deluxe
DLX
$1.22B
$193K 0.1%
+10,208
New +$198K
OFIX icon
409
Orthofix Medical
OFIX
$481M
$186K 0.1%
+14,472
New +$260K
OSG
410
Octave Specialty Group
OSG
$258M
$183K 0.1%
+15,202
New +$204K
ACRE
411
Ares Commercial Real Estate
ACRE
$257M
$182K 0.1%
19,149
-27,673
-59% -$285K
PSFE icon
412
Paysafe
PSFE
$440M
$182K 0.1%
+15,203
New +$185K
SILK
413
DELISTED
Silk Road Medical, Inc. Common Stock
SILK
$182K 0.1%
+12,143
New +$253K
OABI icon
414
OmniAb
OABI
$294M
$181K 0.1%
34,942
-24,852
-42% -$133K
TK icon
415
Teekay
TK
$974M
$181K 0.1%
+29,337
New +$187K
EGRX
416
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
$181K 0.1%
11,473
+1,117
+11% +$20.1K
ARKO icon
417
ARKO Corp
ARKO
$897M
$175K 0.09%
+24,429
New +$191K
GSM icon
418
FerroAtlántica
GSM
$617M
$173K 0.09%
33,213
+21,486
+183% +$112K
OSCR icon
419
Oscar Health
OSCR
$8.54B
$171K 0.09%
30,780
-3,824
-11% -$26.8K
PAX icon
420
Patria Investments
PAX
$1.76B
$171K 0.09%
+11,736
New +$174K
JRVR icon
421
James River Group Holdings
JRVR
$217M
$169K 0.09%
+10,999
New +$179K
PACB icon
422
Pacific Biosciences
PACB
$422M
$164K 0.09%
+19,596
New +$224K
ALTG icon
423
Alta Equipment Group
ALTG
$208M
$163K 0.09%
+13,530
New +$202K
GLAD icon
424
Gladstone Capital
GLAD
$430M
$163K 0.09%
+8,452
New +$175K
MNKD icon
425
MannKind Corp
MNKD
$1.22B
$157K 0.08%
+38,057
New +$171K
15 16
17
18 19

Similar funds

SAF
Smith Anglin Financial Dallas, Texas $1.1B AUM 14.08% 1-Year Est. Return
GIM
Grassi Investment Management Santa Clara, California $1.26B AUM 23.4% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
PP
PrairieView Partners St. Paul, Minnesota $1.03B AUM 11.4% 1-Year Est. Return
FC
Forte Capital Rochester, New York $930M AUM 24.11% 1-Year Est. Return
HIP
HPS Investment Partners New York $1.52B AUM 19.81% 1-Year Est. Return
SC
Savoie Capital Chicago, Illinois $805M AUM 19.48% 1-Year Est. Return
BWA
Bordeaux Wealth Advisors Menlo Park, California $781M AUM 26.55% 1-Year Est. Return

Nebula Research & Development's Q3 2023 Portfolio in Review

As of Q3 2023, Nebula Research & Development held 699 positions worth $190M, up 44% from $132M the previous quarter. Its ten largest holdings account for 5.1% of the portfolio.

Nebula Research & Development deployed $73.8M of net new capital in Q3 2023, opening 375 new positions and adding to 49 existing holdings. Its largest new stake was Louisiana-Pacific: 17,424 shares worth $963K.

By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 19% a quarter earlier, followed by Industrials and Healthcare.

On the sell side, the largest reduction was NexGen Energy, an estimated $632K trimmed.

  • Nebula Research & Development's largest Q3 2023 buy was Louisiana-Pacific: 17,424 shares worth $963K.
  • Nebula Research & Development added most to Hanesbrands in Q3 2023, an estimated $1.04M increase.
  • Nebula Research & Development's biggest Q3 2023 reduction was NexGen Energy, cutting an estimated $632K.
  • Nebula Research & Development fully exited Realty Income in Q3 2023, selling an estimated $636K.
  • Nebula Research & Development's ten largest holdings make up 5.1% of its $190M portfolio in Q3 2023.
  • Nebula Research & Development opened 375 new positions and closed 226 in Q3 2023.
  • Nebula Research & Development's portfolio value rose 44% quarter-over-quarter to $190M.

Based on Nebula Research & Development's 13F filing for Q3 2023, filed 14 Nov 2023.